Improving brain tumor imaging using a new metabolic imaging technique
Enhanced Deuterium Metabolic Imaging (DMI) of Metabolic Reprogramming in Brain Tumors
This study is looking at a new imaging method to see how brain tumors use energy, which could help us learn more about their growth and find better treatments, and patients will have the chance to participate by having special imaging done on their tumors.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11015046 on NIH RePORTER |
What this research studies
This research focuses on enhancing a novel imaging technique called Deuterium Metabolic Imaging (DMI) to better understand how brain tumors metabolize energy. By using deuterated substrates, the study aims to visualize and measure the metabolic processes in brain tumors, particularly how they consume glucose. This approach could provide insights into tumor growth and aggressiveness, potentially leading to more effective treatments. Patients may undergo imaging procedures that help researchers gather data on their tumor metabolism.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with brain tumors, particularly high-grade gliomas.
Not a fit: Patients with non-cancerous brain conditions or those without brain tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment strategies for patients with brain tumors.
How similar studies have performed: Other research has shown promising results using metabolic imaging techniques, suggesting that this approach could be a significant advancement in brain tumor diagnostics.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Spielman, Daniel M — Stanford University
- Study coordinator: Spielman, Daniel M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.